Natco Pharma informs about company updates

10 May 2017 Evaluate

Natco Pharma has informed about Natco launches Pomalid, first generic version of pomalidomide capsules, for treatment of a specific blood cancer, in India.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

951.55 -5.95 (-0.62%)
19-Mar-2026 10:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1761.35
Dr. Reddys Lab 1272.50
Cipla 1254.80
Zydus Lifesciences 884.40
Lupin 2275.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×